264 related articles for article (PubMed ID: 17988821)
1. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
3. Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
Spannuth WA; Thaker PH; Sood AK
Am J Obstet Gynecol; 2007 Apr; 196(4):e6-9. PubMed ID: 17403394
[TBL] [Abstract][Full Text] [Related]
4. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations.
Kelly K; Leventhal H; Andrykowski M; Toppmeyer D; Much J; Dermody J; Marvin M; Baran J; Schwalb M
Psychooncology; 2005 Jan; 14(1):34-48. PubMed ID: 15386791
[TBL] [Abstract][Full Text] [Related]
5. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
[TBL] [Abstract][Full Text] [Related]
6. Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations.
Kelly K; Leventhal H; Marvin M; Toppmeyer D; Much J; Dermody J; Baran J; Schwalb M
Genet Test; 2004; 8(2):139-47. PubMed ID: 15345111
[TBL] [Abstract][Full Text] [Related]
7. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J
Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254
[TBL] [Abstract][Full Text] [Related]
8. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
Brunsvold AN; Wung SF; Merkle CJ
J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
[TBL] [Abstract][Full Text] [Related]
10. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
Hutson SP
Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
[TBL] [Abstract][Full Text] [Related]
11. Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.
Chetrit A; Hirsh-Yechezkel G; Ben-David Y; Lubin F; Friedman E; Sadetzki S
J Clin Oncol; 2008 Jan; 26(1):20-5. PubMed ID: 18165636
[TBL] [Abstract][Full Text] [Related]
12. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
13. Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.
Suthers GK
ANZ J Surg; 2007 May; 77(5):314-9. PubMed ID: 17497966
[TBL] [Abstract][Full Text] [Related]
14. The genetics of ovarian cancer: concepts in testing and counseling.
Hartenbach EM; Schink JC
Curr Opin Obstet Gynecol; 1996 Oct; 8(5):339-42. PubMed ID: 8941429
[TBL] [Abstract][Full Text] [Related]
15. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
16. Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Trivers KF; Baldwin LM; Miller JW; Matthews B; Andrilla CH; Lishner DM; Goff BA
Cancer; 2011 Dec; 117(23):5334-43. PubMed ID: 21792861
[TBL] [Abstract][Full Text] [Related]
17. Patients' resistance to risk information in genetic counseling for BRCA1/2.
Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer.
Calzone KA; Prindiville SA; Jourkiv O; Jenkins J; DeCarvalho M; Wallerstedt DB; Liewehr DJ; Steinberg SM; Soballe PW; Lipkowitz S; Klein P; Kirsch IR
J Clin Oncol; 2005 May; 23(15):3455-64. PubMed ID: 15908654
[TBL] [Abstract][Full Text] [Related]
19. Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors.
Miller SM; Roussi P; Daly MB; Buzaglo JS; Sherman K; Godwin AK; Balshem A; Atchison ME
Health Educ Behav; 2005 Oct; 32(5):654-67. PubMed ID: 16148211
[TBL] [Abstract][Full Text] [Related]
20. Increased risk for familial ovarian cancer among Jewish women: a population-based case-control study.
Steinberg KK; Pernarelli JM; Marcus M; Khoury MJ; Schildkraut JM; Marchbanks PA
Genet Epidemiol; 1998; 15(1):51-9. PubMed ID: 9523210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
